Dopaminergic Medicines used in the treatment of Parkinson’s Disease: Risk of Dopamine Dysregulation Syndrome - SAHPRA

Dopaminergic Medicines used in the treatment of Parkinson’s Disease: Risk of Dopamine Dysregulation Syndrome

Dopaminergic Medicines used in the treatment of Parkinson’s Disease: Risk of Dopamine Dysregulation Syndrome

2021 May

Download latest version
Document Number: DHCPL
Version: 1
Date Updated: 13/05/2021
File Type: pdf
Category: Communication To Health Care Professionals
Unit: Pharmacovigilance